BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 102 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,000 | +20.0% | 5,000 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | -58.3% | 5,000 | -23.2% | 0.00% | – |
| Q2 2019 | $12,000 | +140.0% | 6,509 | +331.3% | 0.00% | – |
| Q1 2019 | $5,000 | 0.0% | 1,509 | -24.9% | 0.00% | – |
| Q4 2018 | $5,000 | -82.8% | 2,009 | -57.6% | 0.00% | – |
| Q3 2018 | $29,000 | -67.4% | 4,735 | -60.7% | 0.00% | – |
| Q2 2018 | $89,000 | +89.4% | 12,058 | +66.0% | 0.00% | – |
| Q1 2018 | $47,000 | +38.2% | 7,262 | +79.0% | 0.00% | – |
| Q4 2017 | $34,000 | -22.7% | 4,058 | +5.0% | 0.00% | – |
| Q3 2017 | $44,000 | +131.6% | 3,866 | +135.7% | 0.00% | – |
| Q2 2017 | $19,000 | -32.1% | 1,640 | -25.6% | 0.00% | – |
| Q1 2017 | $28,000 | – | 2,204 | +10920.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 20 | -89.9% | 0.00% | – |
| Q3 2016 | $4,000 | -85.2% | 198 | -89.1% | 0.00% | – |
| Q3 2015 | $27,000 | +145.5% | 1,823 | +261.0% | 0.00% | – |
| Q2 2015 | $11,000 | +120.0% | 505 | +151.2% | 0.00% | – |
| Q1 2015 | $5,000 | – | 201 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 220,000 | $5,069,000 | 3.43% |
| Perceptive Advisors | 1,046,402 | $24,109,000 | 2.02% |
| Redmile Group, LLC | 860,809 | $17,269,000 | 1.88% |
| Baker Brothers Advisors | 4,283,732 | $98,697,000 | 1.01% |
| RA Capital Management | 1,026,402 | $9,337,000 | 1.00% |
| Ghost Tree Capital, LLC | 75,000 | $1,728,000 | 0.83% |
| ACUTA CAPITAL PARTNERS, LLC | 45,750 | $1,054,000 | 0.71% |
| GREAT POINT PARTNERS LLC | 50,000 | $1,152,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 167,210 | $3,853,000 | 0.33% |
| EMERALD ADVISERS, LLC | 198,202 | $4,567,000 | 0.24% |